|
| |
Interactive Case Study
|
 |
November 2007
1.25 AMA PRA Category 1 Credits™
Expiration date: November 30, 2008
- A 53-Year-Old Male With Recurrent/Metastatic Squamous Cell Cancer of the Head and Neck
|
|
| |
LECTURES
|
Current Trends in Lung and Head & Neck Cancers
March 7, 2008
Atlanta, GA
- Adjuvant Therapy for NSCLC: Where Are We in 2008?
- Combined-Modality Therapy for Stage III NSCLC
- State of the Art in Advanced NSCLC
- What’s New With Angiogenesis Inhibitors in NSCLC?
- Recent Developments With EGFR Inhibition
- Pharmacogenomic Customization of Lung Cancer Therapy
- Novel Agents in Development for NSCLC
- Head and Neck Cancer: Current Clinical Data in 2008
- 2008 Controversies in Head and Neck Cancer
|
|
Translating the Complexities of Cancer Development Into Novel Therapeutics
June 1, 2007
Chicago, IL
- Dual Inhibition of EGFR and VEGF Signal Transduction as a Therapeutic Strategy in Lung Cancer
- Second-Generation Inhibitors of the VEGF Receptor Tyrosine Kinase: Ongoing Studies
- Harnessing SPARC Protein for Enhanced Selective Uptake of Chemotherapy Agents in Tumors
- Targeting the RAF/MEK Pathway in Melanoma and Other Malignancies
- Understanding the Kinome and Its Role in Cancer Pathogenesis
|
|
|
| |
|
 |
Accreditation
Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
|
Disclosure Policy
It is the policy of Physicians’ Education Resource
to ensure balance, independence, objectivity, and scientific rigor in all
of its educational activities. |
|
Privacy Policy
Physicians’ Education Resource (PER) makes reasonable efforts to ensure that privacy issues are handled responsibly. PER does not sell or share your information with other organizations that are not directly involved in this process. If you have further concerns, you may contact us at (888) 949-0045. |
|
